SEC Form 8-K Summary
Registrant: Jupiter Wellness, Inc. The request metadata identifies BONK, Inc., which does not match the registrant named in the filing.
Reporting date: April 1, 2022; filing signed April 5, 2022. This is a current report concerning a material agreement and Regulation FD disclosure, not a periodic financial report.
Business Context and Material Agreement
On April 1, 2022, Jupiter Wellness entered into an exclusive license agreement with Shark Defense Technologies LLC for worldwide intellectual property rights covering formulas and production methods for jellyfish protective compounds, including four pending patents. The agreement also contemplates future collaboration to develop and refine additional formulas.
- The license is worldwide, perpetual, irrevocable, exclusive, and sublicensable.
- Jupiter Wellness must pay the licensor a royalty equal to 6% of net sales, payable in agreed installments not exceeding quarterly installments.
- The exclusivity remains in effect provided aggregate gross sales revenue exceeds $50,000 per year.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial statement metrics. It also does not disclose the expected costs of developing, manufacturing, or commercializing the licensed products.
Changes Versus Prior Period
No comparable-period financial information or prior-period operating metrics are included. The principal reported change is the execution of the new license agreement.
Outlook, Risks, and Unusual Items
The filing includes a press release dated April 5, 2022, but the press release content is not provided in the filing text supplied. Accordingly, any specific guidance or management outlook cannot be assessed.
The agreement creates royalty obligations and requires annual gross sales above $50,000 to maintain exclusive rights. The filing also warns that forward-looking statements are subject to risks and uncertainties, and that actual results may differ materially. No specific regulatory, patent, commercialization, or product-development contingencies are detailed in the supplied text.
Investor Verification Priorities
- Verify the registrant identity: the filing names Jupiter Wellness, Inc., while the request metadata names BONK, Inc.
- Review Exhibit 10.1 for the complete royalty, sales-threshold, termination, patent, and development terms.
- Determine whether the four patent applications have been granted and assess the scope and enforceability of the licensed intellectual property.
- Assess the company’s expected development, manufacturing, regulatory, and commercialization costs.
- Review Exhibit 99.1 for the omitted press release and any additional outlook or product claims.